glp-1 treatment for pre-diabetes GLP-1-based therapies diabetes, obesity and beyond GLP-1 for Prevention: Using Drugs

In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51

De Paepe, M., Leclerc, M., Tinsley, C

Healthier fast food could mean better habits over time

Get access to weight loss medication prescribed online through Ro

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

Compounding pharmacies may change concentrations due to supply chain issues with raw ingredients, changes in compounding regulations, switching to a new supplier, or standardizing their product line